Home›Stock Screener›Chandra Bhagat Pharma›Financial Statements

Chandra Bhagat Pharma Complete Financial Statements

12 Years of Data
2026 - 2015

In FYNone, Chandra Bhagat Pharma (CBPL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 2.5% and ROE of 9.1%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Chandra Bhagat Pharma share price chart.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 2.50% 2026 data
EBITDA Margin 5.83% 2026 data
Operating Margin 3.00% 2026 data
Return on Assets 3.19% 2026 data
Return on Equity 9.09% 2026 data

Balance Sheet Ratios

Current Ratio 29.33 2026 data
Equity Ratio 35.11% 2026 data
Asset Turnover 1.28 2026 data

CBPL Revenue, Net Profit & EBITDA — Year-on-Year Growth

CBPL YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
-7.8%
Year-over-Year
Equity Growth
+10.0%
Year-over-Year
Operating Cash Flow Growth
+250.0%
Year-over-Year
Investing Cash Flow Growth
+100.0%
Year-over-Year
Financing Cash Flow Growth
-400.0%
Year-over-Year

CBPL Income Statement — Revenue, EBITDA & Net Profit

Chandra Bhagat Pharma revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 2.5%. Compare with CBPL DCF valuation to assess whether the stock is under or overvalued.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019
Revenue 0 120 92 233 120 96 71 94 107
Expenses 0 112 88 228 116 91 67 91 102
EBITDA 0 7 4 4 4 4 4 4 5
Operating Profit Margin % 0.00% 3.00% 1.00% -3.00% 3.00% 3.00% 5.00% 3.00% 4.00%
Depreciation 0 1 1 1 0 0 0 0 0
Interest 0 2 2 1 2 3 4 3 4
Profit Before Tax 0 4 1 2 1 1 0 0 1
Tax 0 1 0 1 0 0 0 0 0
Net Profit 0 3 1 2 1 1 0 0 1
Earnings Per Share (₹) 0.00 4.04 1.14 2.03 1.20 1.06 0.25 0.55 13.38

CBPL Balance Sheet — Assets, Liabilities & Shareholders' Equity

CBPL total assets ₹94 Cr, total equity ₹33 Cr, total liabilities ₹ Cr (2026) — ROE 9.1%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019
ASSETS
Total Assets 94 102 102 61 73 72 75 83
Current Assets 88 95 98 58 71 70 73 81
Fixed Assets 3 3 3 1 1 0 0 1
Capital Work in Progress 0 0 0 0 0 0 0 0
Investments 2 0 0 0 0 0 1 4
Other Assets 90 99 99 60 72 71 74 78
LIABILITIES
Total Liabilities
Current Liabilities 3 2 2 6 8 13 15 16
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 33 30 29 28 27 26 26 14
Share Capital 8 8 8 8 8 8 8 1
Reserves & Surplus 26 22 22 20 19 18 18 14

CBPL Cash Flow Statement — Operating, Investing & Financing

Chandra Bhagat Pharma operating cash flow ₹9 Cr, investing ₹0 Cr, financing ₹-6 Cr, net cash flow ₹3 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 9 -6 6 5 12 8 -7 4 -6 -9 0 0
Investing Activities 0 -1 -2 0 0 0 0 0 0 0 0 0
Financing Activities -6 2 -6 -4 -10 -6 7 -4 7 8 0 0
Net Cash Flow 3 -4 -2 1 3 2 0 0 0 -1 0 0